Study on HemoTypeSC™ test for the rapid screening of sickle cell disease patients in Government Medical College and Hospital, Ambikapur

Authors

DOI:

https://doi.org/10.3126/ajms.v13i3.40886

Keywords:

Phenotype HbAA, Phenotype HbAS, Phenotype SC, Sickle cell disease

Abstract

Background: Sickle cell disease (SCD), also known as sickle cell anemia, is a dangerous disease in which the body produces an abnormal form of hemoglobin, the protein in red blood cells that transport oxygen throughout the body. The body produces sickle- or crescent-shaped red blood cells as a result of this genetic change.

Aims and Objectives: This study aims to study on HemoTypeSC™ test for the rapid screening of SCD patients in Government Medical College and Hospital, Ambikapur.

Materials and Methods: Fifty patients have been diagnosed as sickle cell anemia by sickle cell solubility test at Govt. Medical College, Ambikapur, Chhattisgarh,India. All the patients were admitted in the Department of Medicine at Govt. Medical College, Ambikapur, Chhattisgarh,India, from April 1, 2021, to June 1, 2021.

Results: The study group (HbSS patients) comprised 22 (42%) males and 28(58%) females.The ages ranged from 1 to 45 years; these 50 patients have been diagnosed as sickle cell anemia by sickle cell solubility test positive at Govt.Medical College, Ambikapur, Chhattisgarh,India.

Conclusion: Sickle cell illness can be counted and observed in a variety of ways. Experience includes things such as electrophoresis and hand counting. HemoTypeSC™ is a blood test kit that determines hemoglobin type in whole blood in a short amount of time. At the point of care, this test detects the hemoglobin phenotype HbAA (normal), HbSS and HbSC (SCD), HbCC (hemoglobin C illness), and HbAS and HbAC (carrier or trait). Monoclonal antibodies are highly specific and sensitive to hemoglobin’s A, S, and C. The fetal hemoglobin has no effect. There are no liquid buffer components or requirements for refrigeration. In high temperatures, it remains stable and the test takes only 10 min to complete.

Downloads

Download data is not yet available.
Abstract
161
PDF
235

Downloads

Published

2022-03-01

How to Cite

Mahaboob R, S., Obulesu G, Srivastava, R. K., Murthy R, Agarwal, P. ., & Arya R C. (2022). Study on HemoTypeSC™ test for the rapid screening of sickle cell disease patients in Government Medical College and Hospital, Ambikapur. Asian Journal of Medical Sciences, 13(3), 164–169. https://doi.org/10.3126/ajms.v13i3.40886

Issue

Vol. 13 No. 3 (2022)

Section

Original Articles

License

Copyright (c) 2022 Asian Journal of Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).